Information  X 
Enter a valid email address

Tigenix Ord Shs (0EIT)

Date Time Source Announcement
14 Jun 2018 9:00 pm
GNW
Transparency notification pursuant to Article ...
13 Jun 2018 6:00 am
GNW
TiGenix announces a change in its Board of Dire...
06 Jun 2018 6:00 am
GNW
Takeda and TiGenix Announce Results of First Ac...
28 May 2018 9:00 pm
GNW
TiGenix: Transparency notifications pursuant t...
14 May 2018 9:00 pm
GNW
TiGenix:Transparency notifications pursuant to...
08 May 2018 6:00 am
GNW
TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHO...
13 Apr 2018 9:00 pm
GNW
TiGenix: Transparency notification pursuant to...
12 Apr 2018 6:00 am
GNW
TiGenix reports 2017 full year results
10 Apr 2018 9:00 pm
GNW
TiGenix: Transparency notifications pursuant t...
30 Mar 2018 9:00 pm
GNW
TiGenix: Transparency notifications pursuant to...
23 Mar 2018 5:00 pm
GNW
TiGenix and Takeda announce Alofisel® (dar...
06 Feb 2018 9:00 pm
GNW
TiGenix: Transparency Information
31 Jan 2018 9:00 pm
GNW
TiGenix: Transparency notifications pursuant t...
26 Jan 2018 9:00 pm
GNW
TiGenix:Transparency notifications pursuant to...
19 Jan 2018 9:00 pm
GNW
TiGenix: Transparency Information
18 Jan 2018 9:00 pm
GNW
TiGenix: Transparency notification pursuant to...
16 Jan 2018 9:00 pm
GNW
TiGenix: Transparency notifications pursuant t...
15 Jan 2018 6:00 am
GNW
TiGenix announces publication in Gastroenterolo...
12 Jan 2018 9:00 pm
GNW
Transparency notifications pursuant to Article ...
11 Jan 2018 9:00 pm
GNW
TiGenix: Transparency Information
05 Jan 2018 6:30 am
GNW
Takeda announces its intention to acquire TiGenix
03 Jan 2018 9:00 pm
GNW
Transparency notification pursuant to Article 1...
20 Dec 2017 6:00 am
GNW
TiGenix confirms strategic focus on Cx601 and i...
15 Dec 2017 12:11 pm
GNW
Takeda and TiGenix announce that Cx601 (darvads...
14 Dec 2017 11:21 pm
GNW
Mesoblast grants TiGenix an exclusive global pa...
24 Nov 2017 9:00 pm
GNW
JPMorgan Chase & Co notifies 3.12% shareholding...
20 Nov 2017 8:31 am
GNW
TiGenix to present positive 52-week Phase III C...
16 Nov 2017 6:00 am
GNW
TiGenix announces approval of trade name for le...
06 Nov 2017 6:00 am
GNW
TiGenix announces partial conversion of bonds
02 Nov 2017 6:00 am
GNW
TiGenix strengthens European IP protection arou...
31 Oct 2017 6:01 am
GNW
TiGenix provides regulatory update on Cx601 EU ...
23 Oct 2017 6:00 am
GNW
TiGenix granted Orphan Drug Designation from th...
05 Oct 2017 6:00 am
GNW
TiGenix to present positive 52-week Phase III r...
02 Oct 2017 6:00 am
GNW
TiGenix to host Analyst and Investor Event in N...
28 Sep 2017 6:00 am
GNW
TiGenix to participate and present at key inves...
19 Sep 2017 6:00 am
GNW
TiGenix Business and Financial Update for the F...
12 Sep 2017 6:00 am
GNW
TiGenix strengthens US operations with senior a...
05 Sep 2017 6:00 am
GNW
TiGenix obtains commercial production license f...
23 Jun 2017 6:00 am
GNW
TiGenix to present at the 7th TERMIS-EU Confere...
20 Jun 2017 6:00 am
GNW
Takeda and TiGenix announce that Swissmedic has...
15 Jun 2017 6:00 am
GNW
TiGenix Partners with U.S. and European Patient...
13 Jun 2017 6:00 am
GNW
TiGenix Launches Global Phase III Trial for Cx601
12 Jun 2017 6:00 am
GNW
TiGenix announces final equity payment for card...
01 Jun 2017 6:00 am
GNW
TiGenix to present at the Jefferies 2017 Global...
31 May 2017 6:00 am
GNW
TiGenix provides regulatory update on Cx601 EU ...
11 May 2017 6:03 am
GNW
TiGenix to present at Bank of America Merrill L...
10 May 2017 6:02 am
GNW
TiGenix to present at the Crohn's and Colitis F...
04 May 2017 6:00 am
GNW
TiGenix Cx601 positive long-term results to be ...
02 May 2017 6:00 am
GNW
TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHO...
06 Apr 2017 6:01 am
GNW
TiGenix reports 2016 full year results
05 Apr 2017 6:01 am
GNW
TiGenix to participate in key investor conferen...
13 Mar 2017 6:00 am
GNW
TiGenix Announces Top-Line Phase I/II Results o...
09 Mar 2017 6:00 am
GNW
TiGenix Announces Positive Topline Week-104 Dat...
07 Mar 2017 6:00 am
GNW
TiGenix Receives Positive Feedback from the FDA...
06 Mar 2017 6:00 am
GNW
TiGenix Provides Update on Cx601 Marketing Auth...
01 Mar 2017 6:00 am
GNW
TiGenix to present at Cowen's 37th Annual Healt...
17 Feb 2017 8:01 am
GNW
Takeda and TiGenix Report New Data Highlighting...
06 Feb 2017 6:30 am
GNW
TiGenix announces acceptance of Cx601 abstract ...
31 Jan 2017 6:02 am
GNW
TiGenix Enrolls First Patient in Phase Ib/IIa C...
09 Jan 2017 6:00 am
GNW
Takeda notifies 4.48% shareholding in TiGenix
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t